Gene · 4585
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Resistance to Antibody-Drug Conjugates Targeting HER2 in Breast Cancer: Molecular Landscape and Future Challenges. | Cancers (Basel) | 2023 | 36831473 | PubTator, text mining | PubMed |
| Biochemical Characterization of Human Salivary Extracellular Vesicles as a Valuable Source of Biomarkers. | Biology (Basel) | 2023 | 36829504 | PubTator, text mining | PubMed |
| Dietary nucleotides influences intestinal barrier function, immune responses and microbiota in 3-day-old weaned piglets. | Int Immunopharmacol | 2023 | 36827918 | PubTator, text mining | PubMed |
| Association of Sialyl Tn antigen with cervical cancer lymph node status: An NRG oncology/GOG study. | Gynecol Oncol | 2023 | 36827840 | PubTator, text mining | PubMed |
| Knowledge of mucin immunostaining status of "nuclear inverse polarity papillary lesions lacking myoepithelial cells" may prevent unnecessary breast surgery: experience of two cases. | J Int Med Res | 2023 | 36823991 | PubTator, text mining | PubMed |
| Upregulation of galectin-3 in influenza A virus infection promotes viral RNA synthesis through its association with viral PA protein. | J Biomed Sci | 2023 | 36823664 | PubTator, text mining | PubMed |
| MAPKAPK2-centric transcriptome profiling reveals its major role in governing molecular crosstalk of IGFBP2, MUC4, and PRKAR2B during HNSCC pathogenesis. | Comput Struct Biotechnol J | 2023 | 36817960 | PubTator, text mining | PubMed |
| Identification of immune related gene signature for predicting prognosis of cholangiocarcinoma patients. | Front Immunol | 2023 | 36817485 | PubTator, text mining | PubMed |
| MUC16 and TP53 family co-regulate tumor-stromal heterogeneity in pancreatic adenocarcinoma. | Front Oncol | 2023 | 36816942 | PubTator, text mining | PubMed |
| Novel maternal autoantibodies in autism spectrum disorder: Implications for screening and diagnosis. | Front Neurosci | 2023 | 36816132 | PubTator, text mining | PubMed |
| Rare Variants of Dermatofibrosarcoma Protuberans: Clinical, Histologic, and Molecular Features and Diagnostic Pitfalls. | Dermatopathology (Basel) | 2023 | 36810566 | PubTator, text mining | PubMed |
| Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application. | Mol Cancer | 2023 | 36810071 | PubTator, text mining | PubMed |
| The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients. | Eur J Med Res | 2023 | 36805828 | PubTator, text mining | PubMed |
| Effects of β-alanine on intestinal development and immune performance of weaned piglets. | Anim Nutr | 2023 | 36788928 | PubTator, text mining | PubMed |
| [Alveolar rhabdomyosarcoma: novel surrogate markers associated with oncogenic translocation]. | Arkh Patol | 2023 | 36785957 | PubTator, text mining | PubMed |
| Acquired resistance to EGFR-TKIs in NSCLC mediates epigenetic downregulation of MUC17 by facilitating NF-κB activity via UHRF1/DNMT1 complex. | Int J Biol Sci | 2023 | 36778111 | PubTator, text mining | PubMed |
| Identification of PCSK9-like human gene knockouts using metabolomics, proteomics, and whole-genome sequencing in a consanguineous population. | Cell Genom | 2023 | 36777185 | PubTator, text mining | PubMed |
| Integrative proteomic characterization of adenocarcinoma of esophagogastric junction. | Nat Commun | 2023 | 36774361 | PubTator, text mining | PubMed |
| Endometrial Microbiota and Immune Tolerance in Pregnancy. | Int J Mol Sci | 2023 | 36769318 | PubTator, text mining | PubMed |
| Epigenetic Regulation of Corneal Epithelial Differentiation by TET2. | Int J Mol Sci | 2023 | 36769164 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4585/papers?page=33